{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"The Evaluation and Management of Osteoporosis","description":"In this episode, our expert guest challenges a common assumption by explaining why the T-score\u2014despite being central to osteoporosis diagnosis\u2014is surprisingly easy to misinterpret. He walks us through how to read a DEXA scan like a detective, highlighting subtle clues that can dramatically improve diagnostic accuracy for your patients. Once osteoporosis is identified, the conversation turns to clinical decision-making: how to choose between anabolic agents, denosumab, and bisphosphonates, and why that choice depends on thoughtful risk stratification and patient-specific comorbidities. We also dive into the often-overlooked importance of sequencing osteoporosis medications correctly, including a compelling discussion on why starting with an anabolic agent may offer greater long-term benefits than reserving it as a last-line option.  ","author_name":"ACR on Air","author_url":"https:\/\/www.rheumatology.org\/Learning-Center\/Publications-Communications\/Podcast","html":"